Eli Lilly (LLY) Interest Expense — Quarterly & Annual

Screener

Interest Expense at other companies

AmgenAMGN

$673M-3.0%

Cardinal HealthCAH

$101M+36.5%

McKessonMCK

$77M+57.1%

Lexicon PharmaceuticalsLXRX

$1.13M-41.2%

CencoraCOR

-$140.71M-72.0%

Avalo TherapeuticsAVTX

$2.76M+152%

Segments

By segment

Reportable Segment$345M+38.6%

Other financials

Income statement

Revenue$23.0B+47.7%

Gross profit$19.7B+50.3%

Net income$7.1B+25.3%

EPS (diluted)$7.94+26.2%

Balance sheet

Cash & equivalents$9.0B+165%

Total debt$54.9B+37.6%

Total equity$33.9B+85.4%

Total assets$142.28B+41.0%

Cash flow

Operating cash flow$10.7B+246%

CapEx$2.9B+72.8%

Free cash flow$7.8B+458%

Valuation

Market cap$1.06T+58.6%

Enterprise value$1.11T+56.9%

P/E39.8×-8.8×

P/S13.3×+0.8×

Profitability

Gross margin83.4%+0.8pp

Net margin33.5%+7.6pp

FCF margin22.8%+13.7pp

Returns & leverage

Return on equity102.4%+15.7pp

Debt / equity1.6×-0.6×

Current ratio1.4×+0.1×

FAQ

What does interest expense mean?: Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.